subscribeSubscribe
Annora Pharma`s Generic Eltrombopag Receives Approvals in the U.S

Annora Pharma`s Generic Eltrombopag Receives Approvals in the U.S

FDA
18 Apr 2024
Share Share
AbbVie`s Humira tops ICER`s list of drug-pricing worst offenders

AbbVie`s Humira tops ICER`s list of drug-pricing worst offenders
F. Kansteiner FIERCEPHARMA
17 Nov 2021
Share Share
Fostamatinib in chronic immune thrombocytopenia: Added benefit is not proven

Fostamatinib in chronic immune thrombocytopenia: Added benefit is not proven
MEDICAL EXPRESS
06 Oct 2020
Share Share
Novartis strikes out on expanded use of eltrombopag in Europe

Novartis strikes out on expanded use of eltrombopag in Europe
D.W. House SEEKINGAPLPHA
19 Oct 2019
Share Share
AZ bags two extensions in latest CHMP decisions

AZ bags two extensions in latest CHMP decisions
Anna Smith PHARMATIMES
01 Jul 2019
Share Share
Can Dova take on Novartis? With its 2nd Doptelet nod and a price cut, maybe so

Can Dova take on Novartis? With its 2nd Doptelet nod and a price cut, maybe so
Angus Liu FIERCE PHARMA
29 Jun 2019
Share Share
Enforcement Report - Week of May 29, 2019

Enforcement Report - Week of May 29, 2019
FDA
29 May 2019
Share Share
Novartis Issues Voluntary Nationwide Recall of Promacta® 12.5 mg for Oral Suspension

Novartis Issues Voluntary Nationwide Recall of Promacta® 12.5 mg for Oral Suspension
FDA
14 May 2019
Share Share
Amgen Submits SBLA For Nplate® (romiplostim)

Amgen Submits SBLA For Nplate® (romiplostim)
PR NEWSWIRE
19 Dec 2018
Share Share
Novartis scores FDA nod for new Promacta use

Novartis scores FDA nod for new Promacta use
Arlene Weintraub FIERCE PHARMA
21 Nov 2018
Share Share